THERALINK TECHNOLOGIES (THER) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 0 94 sessions, June 28, 2024 to June 30, 2025
- Largest daily move
- +0% close of July 1, 2024
- 1-year change
- +0% closing prices, June 28, 2024 to June 30, 2025
- 1-month change
- +0% closing prices, May 20, 2025 to June 30, 2025
Company Description
THERALINK TECHNOLOGIES (OTC: THER) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $615.1K.
THER has gained 0.0% over the past year. The last closing price was $0.0001.
For FY2023, THERALINK TECHNOLOGIES reported revenue of $607K and diluted earnings per share of -$0.01.
This page collects what Stock Titan holds for THER, including price data, latest news, and financial highlights.
Stock Performance
THERALINK TECHNOLOGIES (THER) closed at $0.0001 on June 30, 2025. Over the past 12 months, the price has gained 0.0%.
THER Metrics & Rankings
Price returns through June 30, 2025. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
THERALINK TECHNOLOGIES has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, earnings, management. View all THER news →
SEC Filings
Financial Highlights
THERALINK TECHNOLOGIES generated $607K in revenue in FY2023, retaining a 79.2% gross margin, and operating income reached -$9.0M (-1479.8% operating margin). Diluted earnings per share stood at -$0.01. The company generated -$5.8M in operating cash flow. The current ratio was 0.03, measuring current assets divided by current liabilities.
Upcoming Events
THER Company Profile & Sector Positioning
THERALINK TECHNOLOGIES (THER) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing THER often look at related companies in the same sector, including SYBLEU INC (SYBE), REGEN BIOPHARMA INC (RGBP), BIO-PATH HOLDINGS INC (BPTH), SQZ BIOTECHNOLOGIES CO (SQZB), and EMMAUS LIFE SCIENCES INC (EMMA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate THER's relative position within its industry.